U.S. Markets closed
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • Dow 30

    30,814.26
    -177.24 (-0.57%)
     
  • Nasdaq

    12,998.50
    -114.10 (-0.87%)
     
  • Russell 2000

    2,123.20
    -32.15 (-1.49%)
     
  • Crude Oil

    52.04
    -1.53 (-2.86%)
     
  • Gold

    1,827.70
    -23.70 (-1.28%)
     
  • Silver

    24.83
    -0.97 (-3.77%)
     
  • EUR/USD

    1.2085
    -0.0079 (-0.6526%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • Vix

    24.34
    +1.09 (+4.69%)
     
  • GBP/USD

    1.3583
    -0.0057 (-0.4143%)
     
  • USD/JPY

    103.8000
    -0.0420 (-0.0404%)
     
  • BTC-USD

    37,260.41
    +1,154.57 (+3.20%)
     
  • CMC Crypto 200

    701.93
    -33.21 (-4.52%)
     
  • FTSE 100

    6,735.71
    -66.25 (-0.97%)
     
  • Nikkei 225

    28,519.18
    -179.12 (-0.62%)
     

MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages CKH, PS, WDR, and EIDX Shareholders to Contact the Firm

·2 min read

NEW YORK, NY / ACCESSWIRE / January 2, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SEACOR Holdings Inc. (NYSE:CKH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to an affiliate of American Industrial Partners for $41.50 per share. If you are a SEACOR shareholder, click here to learn more about your rights and options.

Pluralsight, Inc. (NASDAQ:PS) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Vista Equity Partners for $20.26 per share. If you are a Pluralsight shareholder, click here to learn more about your rights and options.

Waddell & Reed Financial, Inc. (NYSE:WDR) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Macquarie Asset Management for $25.00 per share. If you are a Waddell shareholder, click here to learn more about your rights and options.

Eidos Therapeutics, Inc. (NASDAQ:EIDX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to BridgeBio Pharma, Inc. Under the merger agreement, Eidos stockholders will receive either 1.85 shares of BridgeBio common stock or $73.26 in cash for each share of Eidos common stock owned. If you are an Eidos shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com


SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/622885/MERGER-INVESTIGATION-ALERT-Halper-Sadeh-LLP-Encourages-CKH-PS-WDR-and-EIDX-Shareholders-to-Contact-the-Firm